Breastfeeding Stories and Video Education in Primiparous Mothers

August 21, 2026 updated by: Yeditepe University

The Effect of Successful Breastfeeding Stories and Video-Based Education on Breastfeeding Self-Efficacy and Breastfeeding Success in Primiparous Mothers: A Randomized Controlled Trial

The Effect of Successful Breastfeeding Stories and Video-Based Education on Breastfeeding Self-Efficacy and Breastfeeding Success in Primiparous Mothers: A Randomized Controlled Trial

Objective: This study was planned to determine the effect of the combined use of audio recordings based on successful breastfeeding stories and video-based breastfeeding education on breastfeeding self-efficacy and breastfeeding success among primiparous mothers.

Methods: This study will be conducted using a randomized controlled experimental design. The population of the study will consist of primiparous mothers who give birth at the Obstetrics and Gynecology Clinic of Koç University Hospital between September 2026 and February 2027. The sample will consist of a total of 70 primiparous mothers (35 intervention and 35 control) who meet the inclusion criteria and are assigned to the intervention and control groups using a computer-assisted simple randomization method. In addition to routine breastfeeding education provided at the hospital, mothers in the intervention group will receive audio recordings based on successful breastfeeding stories and video-based breastfeeding education. The control group will receive only the routine breastfeeding education provided at the hospital. Data will be collected using the Descriptive Characteristics Form, Postpartum Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF), LATCH Breastfeeding Assessment Tool, Educational Materials Satisfaction Form, and First-Month Evaluation Form. Data will be analyzed using SPSS version 25.0. Descriptive statistics, independent-samples t-test, paired-samples t-test, chi-square test, and repeated-measures analysis of variance (ANOVA) will be used. The statistical significance level will be accepted as p<0.05.

Expected Results: It is anticipated that the audio recordings based on successful breastfeeding stories and the video-based education program will increase breastfeeding self-efficacy and breastfeeding success among primiparous mothers.

Conclusion: The findings obtained from this study are expected to contribute to the planning of evidence-based nursing interventions aimed at improving breastfeeding self-efficacy and breastfeeding success among primiparous mothers, provide a scientific basis for innovative educational models that can be used to support breastfeeding, and guide the development of standardized breastfeeding education programs that can be implemented in postpartum care services.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
70

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being 18 years of age or older
  • Able to read and write in Turkish
  • Being primiparous
  • Having given birth to a singleton live birth at >37 weeks of gestation
  • Absence of any medical conditions hindering breastfeeding
  • Able to use a smartphone
  • Voluntary agreement to sign written informed consent
  • Having a healthy newborn
  • Presence of the sucking reflex in the infant
  • Absence of neonatal intensive care unit (NICU) admission requirement

Exclusion Criteria:

  • Withdrawal of consent / wishing to leave the study
  • Incomplete completion of data collection tools
  • Infant experiencing severe health issues requiring hospital readmission
  • Loss of contact during the follow-up period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention group
Participants will receive routine hospital breastfeeding education along with audio recordings of successful breastfeeding stories and video-based education.
Behavioral: Routine Breastfeeding Education with Audio Stories and Video Education
In addition to the routine breastfeeding education provided by the hospital, participants in this group receive audio recordings based on successful breastfeeding stories and video-based breastfeeding education.
No Intervention: control group
Participants will receive only routine hospital breastfeeding education.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Breastfeeding Self-Efficacy Scale Short Form (BSES-SF) Score
Time Frame: Baseline (within first 24 hours postpartum) and Postpartum 1st Month (Day 30)
Assessed using the Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF). Total scores range from 14 to 70, with higher scores indicating higher levels of breastfeeding self-efficacy.
Baseline (within first 24 hours postpartum) and Postpartum 1st Month (Day 30)
LATCH Breastfeeding Assessment Tool Score
Time Frame: Baseline (within first 24 hours postpartum) and Discharge day (Day 2-3)
Evaluates breastfeeding performance across 5 parameters (Latch, Audible swallowing, Type of nipple, Comfort, Hold). Total scores range from 0 to 10, with higher scores indicating higher breastfeeding success.
Baseline (within first 24 hours postpartum) and Discharge day (Day 2-3)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
First-Month Evaluation Form
Time Frame: Postpartum 1st Month (Day 30)
Administered by the researcher via phone or online communication methods at the 1st month postpartum. The researcher reads the questions to the participant without guidance and records the responses to evaluate breastfeeding status and outcomes.
Postpartum 1st Month (Day 30)
Education Satisfaction Form Score
Time Frame: Discharge day (Day 2-3)
Evaluates the participants' level of satisfaction with the educational materials provided. Assessed using a structured questionnaire.
Discharge day (Day 2-3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Yeditepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 1, 2027

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 1, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 21, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 21, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 25, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 25, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 21, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2026.332.IRB3.124

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings